Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
J Cancer Res Ther ; 2020 Sep; 16(5): 1093-1099
Article | IMSEAR | ID: sea-213760

ABSTRACT

Purpose: The purpose of this study is to study the clinical outcomes of different types of magnetic resonance (MR)-guided ablation for the treatment of liver tumors by performing a systematic review and pooled analysis. Materials and Methods: A comprehensive literature search was performed for clinical trials published from January 1997 to October 2019 in PubMed, the Web of Science, Embase, and the Cochrane Library. Pooled analyses were performed to obtain the complete ablation (CA), complication, progression-free survival (PFS), and overall survival (OS) rates. Results: Thirty studies were eligible, including four studies on MR-guided microwave ablation (MWA); 14 studies on MR-guided radiofrequency ablation (RFA); one study on both MR-guided MWA and RFA; eight studies on MR-guided, laser-induced thermotherapy (LITT); two studies on MR-guided percutaneous cryoablation (PC); and one study on MR-guided percutaneous ethanol injection (PEI). The CA rates in patients who underwent RFA, MWA, LITT, PC, and PEI were 95.60%, 98.86%, 77.78%, 47.92%, and 85.71%, respectively. The most frequent complications were pain (27.66%, 13/47) and postablation syndrome (27.66%, 13/47) in the PC group; pleural effusion (8.11%, 119/1,468) and subcapsular hematoma (2.25%, 33/1,468) in the LITT group; pleural effusion (2.67%, 2/75) in the MWA group; and subcapsular hematoma (4.18%, 20/478) and post-ablation syndrome (2.93%, 14/478) in the RFA group. There were few studies reporting PFS and OS. Conclusions: MR-guided ablation is a practicable alternative treatment for liver tumors, especially MR-guided RFA and MWA, which have high rates of CA and low occurrences of complications

2.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 13-17, 2010.
Article in Chinese | WPRIM | ID: wpr-341131

ABSTRACT

KCNK17 is a member of the acid-sensitive subfamily of tandem pore K+channels,which are open at all membrane potentials and contribute to cellular resting membrane potential.Recent genome-wide study(GWA)has shown that variants within KCNK17 confer genetic susceptibility for increasing ischemic stroke.In an effort to discover additional polymorphism(s),we scrutinized the genetic polymorphisms in the KCNK17.By direct DNA sequencing in 32 individuals,we identified nine sequence variants within the 16 kb of whole KCNK17 gene: one in exonl,one in intron and seven in the promoter region.Haplotypes,their frequencies and linkage disequilibrium coefficients(D'),among polymorphisms were estimated.All the polymorphisms in the 5'-flanking region(SNP2-SNP7)being in complete(or nearly complete)association with each other in the promoter region maybe produce synergistic effect to regulate the expression of KCNK17 gene and then have an influence on the pathogenesis of cerebrovascular diseases.The common haplotypes were observed comprising 88.9% of the total haplotypes in the same block.Bioinformatic analysis predicted several potential transcriptional factors binding sites by SNP-95,-134,-596 and-846.However,these binding sites need to be experimentally verified.The information concerning genetic polymorphisms of KCNK17 gene might provide valuable information for future genetic studies of diseases.

SELECTION OF CITATIONS
SEARCH DETAIL